期刊文献+

盐酸奥昔布宁醇脂质体的制备及体外透皮吸收研究 被引量:6

Preparation and in vitro transdermal penetration of oxybutynin hydrochloride ethosome
下载PDF
导出
摘要 研究采用乙醇注入均质法制备盐酸奥昔布宁醇质体,正交设计优化处方。用动态光散射测定平均粒径及粒径分布;扫描电子显微镜观测其形态;水平透皮扩散试验仪考察其大鼠离体皮肤经皮渗透量。蛋黄卵磷脂、乙醇、盐酸奥昔布宁的质量分数分别为3%,45%和5%时,制备的醇质体平均粒径为(98±12)nm,包封率为(48.1±1.4)%。各种盐酸奥昔布宁制品24 h的经皮渗透量由大到小依次为:醇脂质体(盐酸奥昔布宁5%)、除去游离药物的醇脂质体(盐酸奥昔布宁2.4%)、物理混合物(盐酸奥昔布宁5%)、无水乙醇(盐酸奥昔布宁5%)、质量分数为45%的乙醇溶液(盐酸奥昔布宁5%)。研究表明醇脂质体是盐酸奥昔布宁经皮给药系统的良好载体。 Oxybutynin hydrochlorid(oxb) ethosomes were prepared by ethonal infusion and homogenization.Orthogonal method was used to optimize the formulation of the ethosomes preparation.The average size and size distribution were determined by dynamic light scattering,and the shape of ethosomes was observed by the scanning electron microscopy.In vitro transdermal flux of oxb through the separated rat skin was determined by Franz-type diffusion cells.The encapsulation efficiency of the ethosomes was(48.1±1.4)%,and the average size was(98±12)nm,when the ethosomal preparation consisted of 3% egg phospholipids,45% ethanol and 5% oxb.Transdermal flux of oxybutynin hydrochloride in various preparations at 24 h was ranked in the order of: ethosomes(oxb 5%)unencapsulate-oxb-free ethosomes(oxb 2.4%)physical mixture(oxb 5%)ethanol solution(oxb 5%)45%ethanol solution(oxb 5%).The results suggested that ethosomes could be the ideal carrier in oxb transdermal delivery.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2011年第1期48-52,共5页 Journal of China Pharmaceutical University
关键词 盐酸奥昔布宁 醇脂质体 正交设计 包封率 经皮渗透量 oxybutynin hydrochloride ethosome orthogonal method encapsulation efficiency transdermal flux
  • 相关文献

参考文献6

  • 1吕惠兰,温清,王本杰,郭瑞臣.健康志愿者盐酸奥昔布宁缓释制剂与普通制剂药代动力学及生物等效性研究[J].山东大学学报(医学版),2005,43(7):657-660. 被引量:3
  • 2Touitou E. Compositions for applying active substances to or through the skin : US,5540934 [ P]. 1996-07-30. 被引量:1
  • 3Jain S, Tiwary AK, Sapra B, et al. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine [ J ]. AAPS PharmSciTech, 2007,8 ( 4 ) : 1 - 9. 被引量:1
  • 4Elsayed MMA, Abdallah OY, Naggar VF, et al. Deformable liposomes and ethosomes : mechanism of enhanced skin delivery [ J ]. lnt J Pharm,2006,322( 1 ) :60 -66. 被引量:1
  • 5Lopez-pinto JM, Gonzalez-Rodriguez ML, Rabasco AM. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes [ J ]. Int J Pharm,2005,298 ( 1 ) : 1 - 12. 被引量:1
  • 6Touitou E,Dayan N,Bergelson L,et al. Ethosomes novel vesicular carriers for enhanced delivery :characterization and skin penetration properties [ J ]. J Control Release,2000,65 ( 3 ) :403 - 418. 被引量:1

二级参考文献5

  • 1Douchamps J, Derenne F , Stockis A, et al. The pharmacokinetics of oxybutynin in man [J]. J Pharmacol,1988, 35:515-520. 被引量:1
  • 2Gayatri S and Suneel KG. Pharmacokinetics of an oral once-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin [J]. J.Clin Pharmacol ,1999, 39:289-296. 被引量:1
  • 3Suneel KG, Michael B, Gayatri S. Effect of OROS controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chloride [J], Br J Clin Pharmacol, 2001,52:409-417. 被引量:1
  • 4Charlotte A, Massad, Barry A Kogan, et al. The pharmacokinetics of intravesical and oral oxybutynin chloride[J].J Urology, 1992, 148:595-597. 被引量:1
  • 5Howard R Zobrist, Bernhard Schmid, Alexander Feick,et al. Pharmacokineties of the R- and S-Enantiomers of oxybutynin and N-Desethyloxybutynin following oral and transdermal administration of the racemate in healthy volunteers [J]. Pharmaceutical Research, 2001,18(7):1 029-1 034. 被引量:1

共引文献2

同被引文献72

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部